Sage Therapeutics, Inc.
Neuroactive steroids and methods of use thereof

Last updated:

Abstract:

Compounds are provided according to Formula (I): ##STR00001## and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R.sup.1, R.sup.2, R.sup.3a, R.sup.3b, R.sup.4, R.sup.5a, R.sup.5b, R.sup.6a, and R.sup.6b are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions.

Status:
Grant
Type:

Utility

Filling date:

20 Dec 2018

Issue date:

31 Aug 2021